Price Matters

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-02-2005
Volume 29
Issue 5

Major pharmaceutical companies are focusing more than ever on the prices CROs are charging for their services.

Recent Videos
Jens Schmidt, associate director MSAT at Lonza
Roger Viney, PhD, chief commercial officer for ICE Pharma
Related Content